| Literature DB >> 34928324 |
Alessandro Rabiolo1,2,3, Federico Fantaguzzi2,3, Riccardo Sacconi2,3, Francesco Gelormini2,3, Enrico Borrelli2,3, Giacinto Triolo4, Paolo Bettin2,3, Andrew I McNaught1,5, Joseph Caprioli6, Giuseppe Querques2,3, Francesco Bandello2,3.
Abstract
Purpose: Compare the ability of peripapillary and macular structural parameters, vascular parameters, and their integration to discriminate among glaucoma, suspected glaucoma (GS), and healthy controls (HCs).Entities:
Mesh:
Year: 2021 PMID: 34928324 PMCID: PMC8709930 DOI: 10.1167/tvst.10.14.20
Source DB: PubMed Journal: Transl Vis Sci Technol ISSN: 2164-2591 Impact factor: 3.283
Figure 1.Quantification of capillary perfusion density for peripapillary (A–D) and macular (E–F) angiograms. Peripapillary en face angiograms were binarized with the Zeiss nerve fiber layer microvasculature density (v0.9) algorithm. The algorithm applies a ring-shaped ROI to the image centered on the ONH with an inner and outer annulus of 2- and 6-mm diameter, excludes large retinal vessels, and quantifies the capillary perfusion density within the ROI area after applying a mask to exclude large retinal vessels. The superimposed green circular dotted line represents the RNFL circle scan used to quantify structural RNFL thickness. Similarly, macular en face angiograms were binarized with the Zeiss superficial and GCIPL analysis (v0.3) algorithm. The algorithm applies a ROI analogous to the GCIPL grid with a radius of 3.0 mm; excludes a central elliptical area (0.5-mm vertical radius and 0.6-mm horizontal radius) corresponding to the foveola; and calculates the capillary perfusion density within the ROI area.
Demographic and Main Clinical Data of Patient Cohort
| Parameters | Glaucoma | GS | HC |
|
|---|---|---|---|---|
| Patients/eyes, | 52/81 | 29/48 | 38/67 | — |
| Age (y), mean ± SD | 62.8 ± 13.5 | 50.2 ± 15.3 | 50.3 ± 14.4 |
|
| Caucasian, | 52 | 29 | 38 | — |
| Male/female, | 20/32 | 16/13 | 16/22 | 0.34 |
| Right eye/left eye, | 40/41 | 23/25 | 34/33 | — |
| SS nerve, median (IQR) | 8.0 (7.0–9.0) | 8.0 (7.0–8.25) | 9.0 (8.0–9.0) |
|
| SS macula, median (IQR) | 8.0 (8.0–9.0) | 8.0 (8.0–9.0) | 9.0 (8.0–9.5) | 0.13 |
| VF MD (dB), median (IQR) | −3.3 (−6.5 to −1.4) | −1.2 (−2.5 to −0.1) | 0.0 (−3.0 to 0.9) |
|
| Disc area (mm2), mean ± SD | 1.9 ± 0.4 | 1.9 ± 0.4 | 1.9 ± 0.3 | 0.72 |
| Rim area (mm2), mean ± SD | 0.9 ± 0.3 | 1.1 ± 0.2 | 1.4 ± 0.3 |
|
GS, glaucoma suspect; HC, healthy control. Bold values indicate a statistical significance at P < 0.05.
Figure 2.Peripapillary RNFL thickness (top left), peripapillary capillary perfusion density (top right), macular GCIPL thickness (bottom left), and macular capillary perfusion density (bottom right) values among patients with glaucoma, patients with suspected glaucoma, and healthy subjects.
Figure 3.ROC curves of peripapillary structural, vascular, and combined structural–vascular parameters to distinguish between patients with glaucoma and either healthy controls (top row) or glaucoma suspects (bottom row). Vertical dotted lines indicate a value of 1-specificity of 0.1. GS, glaucoma suspect.
Figure 4.ROC curves of macular structural, vascular, and combined structural–vascular parameters to distinguish between patients with glaucoma and either healthy controls (top row) or glaucoma suspects (bottom row). Vertical dotted lines indicate a value of 1-specificity of 0.1.
Figure 5.ROC curves of structural, vascular, and combined structural–vascular multisector indices to distinguish between patients with glaucoma and either healthy controls (top row) or glaucoma suspects (bottom row). Vertical dotted lines indicate a value of 1-specificity of 0.1.
Sensitivity at 90% Specificity
| Glaucoma vs. HC (%) | Glaucoma vs. GS (%) | |||||
|---|---|---|---|---|---|---|
| Parameters | Structure | Vasculature | SV Integration | Structure | Vasculature | SV Integration |
| Peripapillary | ||||||
| Average | 74.1 | 29.6 | 74.1 | 53.1 | 29.6 | 54.3 |
| Superior quadrant | 74.1 | 23.5 | 74.1 | 39.5 | 18.5 | 43.2 |
| Nasal quadrant | 17.3 | 14.8 | 22.2 | 7.4 | 24.7 | 24.7 |
| Inferior quadrant | 80.2 | 42.0 | 79.0 | 66.7 | 38.3 | 66.7 |
| Temporal quadrant | 32.1 | 9.9 | 29.6 | 32.1 | 33.3 | 39.5 |
| Macula | ||||||
| Average | 58.0 | 29.6 | 58.0 | 69.1 | 37.0 | 70.4 |
| Superotemporal | 50.6 | 30.9 | 50.6 | 53.1 | 33.3 | 54.3 |
| Superior | 43.2 | 23.5 | 44.4 | 48.1 | 23.5 | 50.6 |
| Superonasal | 46.9 | 19.8 | 48.1 | 53.1 | 23.5 | 53.1 |
| Inferotemporal | 71.6 | 44.4 | 76.5 | 74.1 | 49.4 | 75.3 |
| Inferior | 64.2 | 39.5 | 65.4 | 75.3 | 50.6 | 74.1 |
| Inferonasal | 53.1 | 22.2 | 53.1 | 55.6 | 32.1 | 55.6 |
| Multisector | ||||||
| Elastic net regression | 82.7 | 56.8 | 80.2 | 75.3 | 55.6 | 67.9 |
| Random forest | 80.2 | 49.4 | 81.5 | 76.5 | 54.3 | 74.1 |
| SVM | 84.0 | 43.2 | 84.0 | 69.1 | 54.3 | 74.1 |
| Naïve Bayes | 85.2 | 45.7 | 76.5 | 74.1 | 55.6 | 76.5 |
SV, structural–vascular.